Skip to content

PHARMES

Inactive
KBO/BCE: BE 0773.651.907

Inactive; last annual accounts for financial year 2023. Dissolved and wound up in a single deed on 12-08-2024; books and records kept in Heusden-Zolder.

PHARMESInactive

Overview

Activity
Activity not known
Size
€152,735total assets 2023
Equity
€26,115
Loss
-€84,272
Turnover not published (abbreviated format)
Financial health
Inactive: no score
Structure
Largest shareholder
Cophar · 50%
Auditor: BV BOES JOSEPH-MICHEL BEDRIJFSREVISOR1 of 3 deeds summarised
SignalsneutralLatest accounts filed on timeShow the evidence

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 19-06-2024, 42 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2023
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its 2023 accounts 42 days before the deadline; the Belgian median for financial year 2023 is 3 days before the deadline, and 40% of all filings were late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. End & cessationAppointment: Boes Joseph-Michel Bedrijfsrevisor BV…
  2. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Risk: No longer active Inactive View
  • Total assets 2023first financial year filed €152,735 View

By topic

Financials

Financial year
2023
Total assets
€152,735
Loss
-€84,272
Solvency
17.1%
Go to Financials

Board & ownership

Largest shareholder
Cophar · 50%
Auditor
BV BOES JOSEPH-MICHEL BEDRIJFSREVISOR
Go to Board & ownership

Key facts about PHARMES

What is the company number of PHARMES?
0773.651.907. In Belgium the VAT number is the company number with BE in front: BE 0773.651.907.
What is the legal form of PHARMES?
BV.
Is PHARMES still active?
No. PHARMES is inactive in the KBO register.Company details
What is the turnover of PHARMES?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is PHARMES profitable?
In financial year 2023, PHARMES made a loss of €84,272.
Where can I find the annual accounts of PHARMES?
PHARMES filed 1 annual account with the National Bank of Belgium, for financial year 2023.

Companies related to PHARMES